Evidence map›Paper›PMID 31603187›Full record

ArticleBrain : a journal of neurology2019

Treatment of anti-MDA5 autoantibody-positive juvenile dermatomyositis using tofacitinib.

Sara Sabbagh, Adriana Almeida de Jesus, SuJin Hwang, Hye Sun Kuehn, Hanna Kim, Lawrence Jung, Ruy Carrasco, Sergio Rosenzweig, Raphaela Goldbach-Mansky, Lisa G Rider

Abstract readComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Brain : a journal of neurology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Sara SabbaghMuscle Disease Unit, Laboratory of Muscle Stem Cells and Gene Regulation, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH, Bethesda, MD, USA.
Adriana Almeida de JesusTranslational Autoinflammatory Diseases Section (TADS), LCIM, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD, USA.
SuJin HwangImmunology Service, Department of Laboratory Medicine, NIH Clinical Center, NIH, Bethesda, MD, USA.
Hye Sun KuehnImmunology Service, Department of Laboratory Medicine, NIH Clinical Center, NIH, Bethesda, MD, USA.
Hanna KimPediatric Translational Research Branch, NIAMS, NIH, Bethesda, MD, USA.
Lawrence JungChildren's National Health System, Washington, DC, USA.
Ruy CarrascoPediatric Rheumatology, Specialty for Children, Dell Children's Medical Center, Austin, TX, USA.
Sergio RosenzweigImmunology Service, Department of Laboratory Medicine, NIH Clinical Center, NIH, Bethesda, MD, USA.
Raphaela Goldbach-ManskyTranslational Autoinflammatory Diseases Section (TADS), LCIM, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD, USA.
Lisa G RiderEnvironmental Autoimmunity Group, Clinical Research Branch, National Institute of Environmental Health Sciences (NIEHS), NIH, Bethesda, MD, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

DermatomyositisInterferon Type IAutoantibodiesHumansPiperidinesPyrimidinesPyrrolesAutoantibodiesInterferon Type IPiperidinesPyrimidinesPyrrolestofacitinib

Identifiers

PMID31603187
PMCPMC6821280

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.